Sorry - There were no pages found that contain that search phrase.
 |
 |
 |
 |
|
 |
Showing Treatment 1 to 25 of 62 Next 25 |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Chicago, IL |
 |
09/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
 |
Chicago, IL USA |
 |
08/11/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Chicago, IL USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Chicago, IL USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Chicago, IL USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Evanston, IL USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
|
 |
Chicago, IL USA |
 |
11/08/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Maywood, IL USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Harvey, IL USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Chicago, IL USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
 |
Chicago, IL USA |
 |
03/01/2008 |
 |
 |
 |
 |
 |
Details |
 |
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
 |
Evanston, IL USA |
 |
03/01/2008 |
 |
 |
 |
Details |
 |
A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas |
 |
Chicago, IL USA |
 |
08/20/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme |
 |
Chicago, IL USA |
 |
08/19/2007 |
 |
 |
 |
Details |
 |
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel® in Subjects With Recurrent Glioma |
 |
Chicago, IL USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
 |
Chicago, IL USA |
 |
06/04/2007 |
 |
 |
 |
Details |
 |
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma |
 |
Chicago, IL USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Harvey, IL USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Chicago, IL USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Park Ridge, IL USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
 |
Park Ridge, IL USA |
 |
10/12/2006 |
 |
 |
 |
 |
 |
Details |
 |
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
 |
Chicago, IL USA |
 |
10/12/2006 |
 |
 |
 |
Details |
 |
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
 |
Chicago, IL USA |
 |
10/12/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
 |
Urbana, IL USA |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
 |
Peoria, IL USA |
 |
06/26/2006 |
 |
 |
 |
 |
 |